Who have thought a complete calendar year ago that the patents on the breast cancer genes BRCA1 and BRCA2, held by Myriad Genetics, will be overturned by a US federal court? Or a federal judge would upend President Barack Obama’ temporarily;s executive order allowing funding for research involving human embryonic stem cells? Furthermore, 2010 saw a shake-up for the genetic screening industry following the US Meals and Drug Administration and Government Accountability Office voiced problems about the direct-to-customer spit kits. Meanwhile, some individuals claiming to cure individuals with stem cell treatments drew the ire of regulatory agencies also. August In, the FDA attempted to crack down on Colorado-based Regenerative Sciences, within the UK, Robert Trossel lost his doctor’s license after treating multiple sclerosis sufferers with stem cell shots.John's University School of Pharmacy in 1992. He has released over 210 peer-examined manuscripts, four texts, 15 reserve chapters, and provides been invited to give more than 150 presentations world-wide. Dr. Khan's analysis focuses primarily in the area drug formulations style and development of ‘challenging molecules.’ It encompasses pediatric dosage forms, nanoparticles, modified launch dosage forms, biosimilar characterization, particulate engineering, and scientific underpinnings of Quality by Style utilizing novel Procedure Analytical Technology.